Carpal Tunnel Syndrome Treatment: Surgery Vs. Injections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective randomized controlled study included 68 patients (aged 18-70) with mild to moderate carpal tunnel syndrome (CTS), randomized into three groups: surgical treatment (25 patients, 25 wrists), corticosteroid (CS) treatment (20 patients, 32 wrists), and platelet-rich plasma (PRP) treatment (23 patients, 35 wrists). Diagnosis was confirmed through clinical evaluation and electrodiagnostic (EDX) testing, with assessments including the Visual Analog Scale (VAS), Boston Carpal Tunnel Questionnaire (BCTQ), ultrasonographic median nerve cross-sectional area (CSA) and flattening ratio (FR), and sensory/motor conduction parameters. Treatments were ultrasound-guided CS (1 mL triamcinolone, 40 mg/mL) or PRP (1 mL extracted from centrifuged venous blood) injections, while surgical treatment involved standard open carpal tunnel release using the WALANT (Wide Awake Local Anesthesia No Tourniquet) technique. Follow-ups were conducted at 1, 3, and 6 months, and the study was ethically approved with informed patient consent.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Platelet Rich Plasma in Carpal Tunnel Syndrome

NCT04000932

Carpal Tunnel Syndrome

UNKNOWN PHASE3

Ultrasound-Guided Injection vs Intramuscular Steroid for Carpal Tunnel Syndrome

NCT06725420

Carpal Tunnel Syndrome (CTS) Chronic Pain

COMPLETED NA

Effectiveness of Corticosteroid and 5% Dextrose Versus USG-guided Ozone Injections in Patients With Carpal Tunnel Syndrome: Three Blind Randomized Studies

NCT07002892

Carpal Tunnel Syndrome Treatment

RECRUITING NA

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

NCT06243848

Musculoskeletal Diseases Median Nerve Disease Carpal Tunnel Syndrome +2 more

RECRUITING NA

Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome

NCT05475808

Carpal Tunnel Syndrome

ACTIVE_NOT_RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome (CTS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

surgery group

Group Type ACTIVE_COMPARATOR

open carpal tunnel surgery

Intervention Type PROCEDURE

open carpal tunnel surgery

steroid injection group

Group Type ACTIVE_COMPARATOR

Steroid Injection

Intervention Type PROCEDURE

triamsinolon injection

prp injection group

Group Type ACTIVE_COMPARATOR

PRP injection

Intervention Type PROCEDURE

PRP injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

open carpal tunnel surgery

Intervention Type PROCEDURE

Steroid Injection

triamsinolon injection

Intervention Type PROCEDURE

PRP injection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

minimum of 3 months duration of symptoms and mild to moderate CTS

Exclusion Criteria

* 1\) Patients with severe CTS diagnosed with EMG or the presence of thenar atrophy, 2) Polyneuropathy, 3) Previous injection therapy for CTS, 4) Previous CTS surgery, 5) Pregnancy or lactation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No